Form 8-K - Current report:
SEC Accession No. 0000950170-24-011269
Filing Date
2024-02-05
Accepted
2024-02-05 16:29:04
Documents
12
Period of Report
2024-02-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K alks-20240201.htm   iXBRL 8-K 48033
  Complete submission text file 0000950170-24-011269.txt   169479

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alks-20240201.xsd EX-101.SCH 30799
14 EXTRACTED XBRL INSTANCE DOCUMENT alks-20240201_htm.xml XML 4683
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 24596108
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)